You are here

  • Home
  • Archive
  • Volume 30, Issue 4
  • The use of recombinant activated factor VII (rFVIIa) in the management of patients with major haemorrhage in military hospitals over the last 5 years

Article info

Article menu
Download PDFPDF
Original article
The use of recombinant activated factor VII (rFVIIa) in the management of patients with major haemorrhage in military hospitals over the last 5 years

Authors

  • J E Smith Academic Department of Military Emergency Medicine, Royal Centre for Defence Medicine, Birmingham, UKEmergency Department, Derriford Hospital, Plymouth, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Surg Cdr J E Smith RN, Senior Lecturer, Academic Department of Military Emergency Medicine, RCDM, Institute of Research and Development, Vincent Drive, Birmingham B15 2SQ, UK; jasonesmith{at}doctors.org.uk
View Full Text

Citation

Smith JE
The use of recombinant activated factor VII (rFVIIa) in the management of patients with major haemorrhage in military hospitals over the last 5 years
Emergency Medicine Journal 2013;30:316-319.

Publication history

  • Accepted April 10, 2012
  • First published May 19, 2012.
Online issue publication 
April 29, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions